Brief: Cantargia Presents New Results At EADV 2024

Cantargia AB

25/09/2024 07:03

Sept 25 (Reuters) - Cantargia AB  CANTA.ST :
    * PRESENTS NEW RESULTS AT EADV 2024 HIGHLIGHTING THE
POTENTIAL OF
CAN10 TREATMENT IN DERMATOLOGY
    * TREATMENT EFFECT OF CAN10 IN MODELS OF SKIN INFLAMMATION
WAS
POTENT AND SUPERIOR TO IL-1Β BLOCKADE
    * PRECLINICAL EXPERIMENTS SHOWING HIGH POTENTIAL OF IL1RAP
TARGETING ANTIBODY CAN10 IN TREATMENT OF DERMATOLOGICAL DISEASES

Source text for Eikon:  ID:nMFN296Cwg 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))